On December 8th, the United Kingdom administered the first doses of the vaccine developed by BioNTech-Pfizer. The spread of Covid-19 in Britain was the strongest in Europe as winter approached. According to the Worldometers, an international statistics website, the cumulative number of confirmed cases has continued to increase steeply since October, and the UK’s newly confirmed cases have already surpassed 20,000.
The British government approved the emergency use of the Covid-19 vaccine for the first time in the world and started vaccinating its citizens on December 8th. The first person to be vaccinated was Margaret Keenan, a former jewelry shop assistant soon to be 91.
"It's the best early birthday present I could wish for. I can finally spend time with my family and friends in the New Year after being on my own for most of the year." Ms. Keenan said.
The BBC reported on the 11th that about 800,000 doses are expected to be administered at 70 hospitals, and 25 million people who are vulnerable to COVID-19 will be vaccinated first. Since the vaccines of BioNTech-Pfizer have to be administered twice every 21 days, the effects of the vaccination should wait.
While more than 10,000 confirmed cases are occurring in Europe every day, the U.S. has more than 16 million confirmed cases. According to the White House, the US government is expected to approve the Pfizer COVID-19 vaccine as the FDA advisory committee voted in favor of approving the emergency use for those aged 16 years and older. Gustave Perna of Operation Warp Speed, the Trump administration's vaccine development program, told at the conference on December 12th that three million doses of the vaccine are to be shipped to the states this weekend.
The COVID-19 vaccines currently are developing by the world's leading pharmaceutical companies in the U.S., the U.K, Russia, and more and the start of inoculation is giving hope in the fight against the virus. However, the world is still having a tough end of the year struggling against the virus while getting the vaccine.